Stock PBM PSYENCE BIOMEDICAL LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Psyence Biomedical Ltd.

Equities

PBM

CA74449F1009

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
 03:30:00 27/06/2024 am IST 		5-day change 1st Jan Change
0.329 USD -7.53% Intraday chart for Psyence Biomedical Ltd. -15.64% -96.44%
18/03 Psyence Biomedical Ltd. Announces Results of Recent Study Highlighting Benefits of Nature Derived Psilocybin Vs. Synthetic Psilocybin CI
12/03 Psyence Biomedical Ltd. Receives Human Research Ethics Committee Approval to Initiate Phase IIb Study CI

Valuation

Fiscal Period: March 2022 2023
Capitalization 1 408.9 132
Enterprise Value (EV) 1 406.7 130.2
P/E ratio - -
Yield - -
Capitalization / Revenue - -
EV / Revenue - -
EV / EBITDA - -
EV / FCF - -35,08,25,646 x
FCF Yield - -0%
Price to Book - -
Nbr of stocks (in thousands) 32,675 9,178
Reference price 2 12.51 14.39
Announcement Date 15/11/23 15/11/23
1CAD in Million2CAD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023
Net sales - -
EBITDA - -
EBIT 1 -2.317 -4.276
Operating Margin - -
Earnings before Tax (EBT) 1 -2.32 -4.238
Net income 1 -2.32 -4.238
Net margin - -
EPS - -
Free Cash Flow - -0.3712
FCF margin - -
FCF Conversion (EBITDA) - -
FCF Conversion (Net income) - -
Dividend per Share - -
Announcement Date 15/11/23 15/11/23
1CAD in Million
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023
Net Debt 1 - -
Net Cash position 1 2.19 1.81
Leverage (Debt/EBITDA) - -
Free Cash Flow - -0.37
ROE (net income / shareholders' equity) - -458%
ROA (Net income/ Total Assets) - -120%
Assets 1 - 3.52
Book Value Per Share - -
Cash Flow per Share - -
Capex - -
Capex / Sales - -
Announcement Date 15/11/23 15/11/23
1CAD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Pharmaceuticals

1st Jan change Capi.
PSYENCE BIOMEDICAL LTD. Stock Psyence Biomedical Ltd.
-96.44% 4.02M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+55.32% 815B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+44.05% 641B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.75% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+13.56% 314B
ABBVIE INC. Stock AbbVie Inc.
+10.68% 303B
ASTRAZENECA PLC Stock AstraZeneca PLC
+16.57% 242B
NOVARTIS AG Stock Novartis AG
+13.31% 218B
AMGEN INC. Stock Amgen Inc.
+8.48% 168B
PFIZER, INC. Stock Pfizer, Inc.
-2.81% 159B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. PBM Stock
  4. Financials Psyence Biomedical Ltd.